NEW YORK (GenomeWeb) – Illumina announced after the close of the market Wednesday that it plans to launch a $900 million convertible senior notes offering.

The firm said it proposes to offer $450 million of notes due 2019 and $450 million in notes due 2021. In addition, it intends to grant the initial purchasers a 30-day option to purchase up to an additional $67.5 million in aggregate principal amount of the notes due 2019 and an additional $67.5 million of the notes due 2021, which would bring the total potential offering size to around $1 billion.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

The Economist writes that an increasing number of scientific journals don't do peer review.

In Science this week: genetic overlap among many psychiatric disorders, and more.